ArticleAging cell2019

Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease.

Benoît Melchior et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.